Phase I trial of EOS884448 safety and efficacy.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2018
At a glance
- Drugs EOS-884448 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 14 Feb 2018 New trial record
- 09 Feb 2018 According to iTeos Therapeutics media release, trial expected to begin in 2019.